AMS Advanced Medical Services
AMS Advanced Medical Services is recorded as a service provider in 11 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 11 of 11 trials · Latest update first
Multi-centre, double-blind, placebo-controlled, randomised trial to prove the efficacy and safety of Silexan® (WS®1265) in patients with a major depressive episode of mild to moderate severity
Sponsor Dr. Willmar Schwabe GmbH & Co. KG
- Start (EU)
- Latest update
- Estimated end
- Not reported
A randomized, open-label, multicentric, two-arm pivotal trial of SonoCloud-9 combined with carboplatin (CBDCA) vs standard of care lomustine (CCNU) or temozolomide (TMZ) in patients undergoing planned resection for first recurrence glioblastoma
Sponsor Carthera
- Start (EU)
- Latest update
- Estimated end
A Long-term, Open-label Study to Evaluate the Safety and Efficacy of Orally Administered Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema
Sponsor Pharvaris Netherlands B.V.
- Start (EU)
- Latest update
- Estimated end
A randomized, open-label, reference-replicated crossover trial to investigate the bioequivalence of two formulations of Silexan 80 mg in healthy volunteers
Sponsor Dr. Willmar Schwabe GmbH & Co. KG
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase III randomised, double-blind, placebo-controlled, multicentre efficacy and safety clinical trial of angiotensin II in paediatric patients of 0 to 17 years of age with refractory hypotension in distributive shock receiving fluid resuscitation and standard-of-care vasopressors
Sponsor Paion Pharma GmbH
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Orally Administered Deucrictibant Extended-release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema
Sponsor Pharvaris Netherlands B.V.
- Start (EU)
- Latest update
- Estimated end
An open-label study to provide berotralstat access to subjects with type I and II hereditary angioedema who were previously enrolled in berotralstat studies
Sponsor Biocryst Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
A PHASE 1/1B STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND IMMUNOGENICITY OF SINGLE AND MULTIPLE ASCENDING DOSES OF BCX17725 IN HEALTHY PARTICIPANTS AND MULTIPLE DOSES OF BCX17725 IN PARTICIPANTS WITH NETHERTON SYNDROME
Sponsor Biocryst Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
A Prospective, Randomized, Controlled, Multinational, Phase 2/3, Open-Label Trial to Evaluate the Efficacy and Safety of SIL204-SL Administered as an Integrated Therapeutic Regimen in Combination with Chemotherapy vs. Chemotherapy Treatment Alone in Participants with Locally Advanced Pancreatic Cancer
Sponsor Silexion Therapeutics Ltd.
- Start (EU)
- Not reported
- Latest update
- Estimated end
Randomized, double-blind, placebo-controlled, multi-centre trial to evaluate the efficacy, safety and tolerability of oral treatment with living bacteria of E. coli DSM 17252 (Symbioflor®2) in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D)
Sponsor SymbioPharm GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
A non-randomised, open-label, uncontrolled, multi-centre, phase IIIb study evaluating the safety and efficacy of fluocinolone acetonide 190 micrograms intravitreal implant in paediatric subjects from 6 years to less than 18 years with recurrent non-infectious uveitis affecting the posterior segment of the eye.
Sponsor Alimera Sciences Europe Limited
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for AMS Advanced Medical Services?
The 2026-10-09 snapshot links AMS Advanced Medical Services to 11 distinct CTIS trials. Recorded services include Clinical monitoring, Investigator recruitment, Project management, Medical writing, among 11 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for AMS Advanced Medical Services?
The most frequently recorded therapeutic areas are Neurology, Psychiatry, Solid Tumor Oncology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to AMS Advanced Medical Services conducted?
The linked trials record locations in 16 countries, including Germany, France, Spain, Italy, Austria. These are trial locations, not confirmed office locations or countries where AMS Advanced Medical Services delivered services.
What can this page tell me about AMS Advanced Medical Services's trial experience?
Browse 11 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 2 recorded name variants under AMS Advanced Medical Services. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- AMS Advanced Medical Services GmbH
- AMS Advanced Medical Services Limited